{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T17:05:41Z","timestamp":1795280741626,"version":"4.10.3"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jclinepi.2026.112548","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:37:54Z","timestamp":1791243474000},"page":"112548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Addressing limited evidence in guideline development"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2498-1697","authenticated-orcid":false,"given":"Andrea J.","family":"Darzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7087-8543","authenticated-orcid":false,"given":"Emily","family":"Sirotich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4361-0792","authenticated-orcid":false,"given":"Saifur R.","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Guyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jclinepi.2026.112548_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13023-017-0755-5","article-title":"An overview of the impact of rare disease characteristics on research methodology","volume":"13","author":"Whicher","year":"2018","journal-title":"Orphanet J rare Dis"},{"key":"10.1016\/j.jclinepi.2026.112548_bib2","article-title":"Core GRADE 5: rating certainty of evidence\u2014assessing indirectness","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2026.112548_bib3","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence\u2014indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2026.112548_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2025.112099","article-title":"A decision algorithm for assessing indirectness in core GRADE","volume":"190","author":"Guyatt","year":"2026","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2026.112548_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jclinepi.2018.02.026","article-title":"Do clinicians want recommendations? A multicenter study comparing evidence summaries with and without GRADE recommendations","volume":"99","author":"Neumann","year":"2018","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.jclinepi.2026.112548_bib6","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1503\/cmaj.190144","article-title":"Guideline groups should make recommendations even if the evidence is considered insufficient","volume":"192","author":"Neumann","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.jclinepi.2026.112548_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081903","article-title":"Core GRADE 1: overview of the core GRADE approach","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2026.112548_bib8","article-title":"Distinguishing opinion from evidence in guidelines","volume":"366","author":"Sch\u00fcnemann","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2026.112548_bib9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jama.2019.9751","article-title":"Evidence vs consensus in clinical practice guidelines","volume":"322","author":"Djulbegovic","year":"2019","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jclinepi.2026.112548_bib10","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1002\/jbmr.4691","article-title":"Evaluation and management of hypoparathyroidism summary statement and guidelines from the second international workshop","volume":"37","author":"Khan","year":"2022","journal-title":"J Bone Mineral Res"},{"key":"10.1016\/j.jclinepi.2026.112548_bib11","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/jth.14192","article-title":"McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome","volume":"16","author":"Legault","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jclinepi.2026.112548_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/hae.13008","article-title":"NHF-McMaster guideline on care models for haemophilia management","volume":"22","author":"Pai","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.jclinepi.2026.112548_bib13","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1182\/bloodadvances.2025017934","article-title":"American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults","volume":"10","author":"Sekeres","year":"2026","journal-title":"Blood Adv"},{"key":"10.1016\/j.jclinepi.2026.112548_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/JMDH.S104807","article-title":"Information bias in health research: definition, pitfalls, and adjustment methods","volume":"9","author":"Althubaiti","year":"2016","journal-title":"J Multidiscip Healthc"},{"issue":"18","key":"10.1016\/j.jclinepi.2026.112548_bib15","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1182\/bloodadvances.2021004394C","article-title":"American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation","volume":"5","author":"Kanter","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jclinepi.2026.112548_bib16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1197\/jamia.M1087","article-title":"Defining and improving data quality in medical registries: a literature review, case study, and generic framework","volume":"9","author":"Arts","year":"2002","journal-title":"J Am Med Inform Assoc"},{"issue":"2","key":"10.1016\/j.jclinepi.2026.112548_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000444476","article-title":"The quality of rare disease registries: evaluation and characterization","volume":"19","author":"Coi","year":"2016","journal-title":"Public Health Genomics"},{"key":"10.1016\/j.jclinepi.2026.112548_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-319-67144-4_8","article-title":"Data quality in rare diseases registries","volume":"1031","author":"Kodra","year":"2017","journal-title":"Rare Dis Epidemiol Update overview"},{"key":"10.1016\/j.jclinepi.2026.112548_bib19","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1182\/bloodadvances.2025018818","article-title":"Guideline on the emergency management of critical bleeding in patients with immune thrombocytopenia","volume":"10","author":"Chowdhury","year":"2026","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jclinepi.2026.112548_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/0194599817717676","article-title":"The challenge of guideline development when evidence is sparse","volume":"157","author":"Scharpf","year":"2017","journal-title":"Otolaryngology\u2013Head Neck Surg"},{"issue":"6","key":"10.1016\/j.jclinepi.2026.112548_bib21","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3233\/JND-200536","article-title":"The rare knowledge mining methodological framework for the development of practice guidelines and knowledge translation tools for rare diseases","volume":"8","author":"Gagnon","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.jclinepi.2026.112548_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12874-019-0713-0","article-title":"Strategies for eliciting and synthesizing evidence for guidelines in rare diseases","volume":"19","author":"Pai","year":"2019","journal-title":"BMC Med Res Methodol"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435626004245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435626004245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:38:54Z","timestamp":1793284734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435626004245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":22,"alternative-id":["S0895435626004245"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2026.112548","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addressing limited evidence in guideline development","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2026.112548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112548"}}